BRIEF-EMA Recommends Withdrawal Of Pholcodine Medicines From EU Market

BRIEF-EMA Recommends Withdrawal Of Pholcodine Medicines From EU Market
Representative image

European Medicines Agency: * EMA: EMA RECOMMENDS WITHDRAWAL OF PHOLCODINE MEDICINES FROM EU MARKET: 02/12/2022

* EMA - HEALTHCARE PROFESSIONALS SHOULD CONSIDER APPROPRIATE TREATMENT ALTERNATIVES AND ADVISE PATIENTS TO STOP TAKING PHOLCODINE-CONTAINING MEDICINES * EMA- DATA SHOWED USE OF PHOLCODINE IN YEAR BEFORE GENERAL ANAESTHESIA WITH NMBA IS RISK FACTOR FOR DEVELOPING ANAPHYLACTIC REACTION TO NMBAS

* EMA-PRAC RECOMMENDATIONS WILL NOW BE SENT TO COORDINATION GROUP FOR MUTUAL RECOGNITION AND DECENTRALISED PROCEDURES FOR CONSIDERATION AT DEC MEETING

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.